There was no evidence of association between the FANCC variants and breast cancer risk, either for carriers of both variants combined (OR 0.77, 95%CI 0.44–1.33, p = 0.35), or for either variant individually (Table 1). This evidence concerns the gene FANCC and breast cancer.